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1 
INTRODUCTION 
 
 Obesity has increased globally in an alarmic proportion in the 
last 30 years [1]. Complications due to obesity has surpassed that of many 
infectious  diseases in developed countries. Global epidemic of obesity has 
also affected Indians[2]. India has been ranked 3rd in the list of top 10 
countries with highest number of obese people just behind U.S and China. 
Obesity carries significant risk for the development of Hypertension, 
Diabetes mellitus, Heart diseases, Stroke and some Cancers[3] .Obesity 
adversely affects Respiratory system also[4]. 
Obesity  causes reduction of  Lung  compliance  leading to decrease in 
lung volumes  producing  mostly a restrictive type of ventilatory defect. 
Compression of thoracic cage by excessive fat and increased pooling of blood 
in pulmonary vasculature mainly contribute towards reduction in respiratory 
compliance. Deposition of fat in diaphragm  causes mechanical obstruction to 
the descent of diaphragm there by causing increased work of breathing and 
metabolic demand there by producing breathing difficulty                           
WHO recommends BMI for defining obesity.  BMI has been reported 
to be negatively associated with values for dynamic lung volumes including 
forced vital capacity (FVC) and forced expiratory volume in first second 
(FEV1) [5] 
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Association between BMI and pulmonary function has  been previously 
examined  but not much studies are available in India. Therefore, the present 
study is conducted to measure  the relationship between BMI  and lung 
volumes in a sample of local population of 15 to 60 yrs age group of 
apparently healthy individuals attending Master Health Check Up OP and  
attenders of in-patients of wards of general medicine department, Govt. 
Chengalpattu Medical College, Chengalpattu. 
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AIM OF STUDY 
 
AIM  AND OBJECTIVES OF THE STUDY : 
1. To measure the association of body mass index (BMI) to dynamic lung 
volumes assessed by Digital Spirometer 
2. Comparing  the study with similar studies done already in other reputed 
centres 
          
 
                                
 
 
 
 
 
 
 
 
4 
REVIEW OF LITERATURE 
  
OBESITY 
Introduction 
 In a world where food supplies are intermittent, the ability to store 
energy in excess of what is required for immediate use is essential for survival. 
  Fat cells, residing within widely distributed adipose tissue depots, are 
adapted to store excess energy efficiently as triglyceride. When needed,  these  
fat cells  release stored energy as free fatty acids for use at other sites. This 
physiologic system,mediated  through endocrine and neural pathways, permits 
humans to survive starvation for as long as several months.  
 However, in the presence of nutritional abundance and a sedentary 
lifestyle, and influenced importantly by genetic endowment, this system 
increases adipose  energy stores and  obesity develops which produces adverse 
health consequences. 
Historical aspects 
 The word Obesity is derived  from the Latin word obesitas, which 
means "stout, fat, or plump". Obesity has been known since ancient times. 
Ancient Greek medicine describes obesity as a medical disorder  and the 
Ancient Egyptians also saw it in the same way[6]. Hippocrates mentioned 
about obesity that "Corpulence is not only a disease itself, but the harbinger of 
others". 
5 
  The Ancient great Indian surgeon Sushruta (6th century BC)  also 
mentioned about obesity and related obesity to diabetes and heart disorders[7]. 
He recommended physical work to help cure it and its side effects. 
Definition:   
          “Obesity is a medical condition in which excess body fat  accumulates 
to the extent that it may have an adverse effect on health”.  
Measurement 
 The most widely used method to gauge obesity is the body mass index 
(BMI), which is equal to weight/height2 (in kg/m2) . Other approaches to 
quantifying obesity include anthropometry (skinfold thickness), densitometry 
(underwater weighing), CT or MRI, and  electrical impedance[8, 28]. BMI is 
closely related to both percentage body fat and total body fat[9].   
Prevalence 
 In U.S more than 20 % of population is obese. In India about 11% of 
population is obese and  about 5% are morbidly obese.In urban schools more 
than 15% school children are obese. According to a study published in the 
noted journal Lancet, India is just behind US and China in this global hazard 
list of top 10 countries with highest number of obese[10]. people.  Unhealthy, 
processed food has become much more accessible following India's continued 
integration in global food markets. 
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  This, combined with rising middle class incomes, is increasing the 
average caloric intake per individual among the middle class and above 
income households.   
Physiologic Regulation of Energy Balance: 
 Substantial evidence suggests that body weight is regulated by both 
endocrine and neural components that ultimately influence the  energy intake 
and expenditure.This  complex regulatory system is necessary because even 
small imbalances between energy intake and expenditure will ultimately have 
large effects on body weight.For example, a 0.3% positive imbalance over 30 
years would result in a 9-kg (20-lb) weight gain. 
  This  regulation of energy balance cannot be monitored simply by 
calorie-counting in relation to physical activity. Rather, body weight 
regulation or dysregulation depends on a complex interplay of hormonal and  
neural signals. 
  Alterations in stable weight by forced overfeeding or food deprivation 
induce physiologic changes that resist these perturbations: 
x with weight loss, appetite increases and energy expenditure falls; 
x with overfeeding, appetite falls and energy expenditure increases. 
  This latter compensatory mechanism frequently fails, however, 
permitting obesity to develop  when food is abundant and physical activity is 
limited. A major regulator of these adaptive responses is the adipocyte-derived 
hormone leptin, which acts through brain circuits (predominantly in the 
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hypothalamus) to influence appetite, energy expenditure, and  neuroendocrine 
function . 
Syndromes associated with Obesity 
 A number of syndromes has been reported to be associated with 
obesity[11].Some of these are given below 
x Prader-Willi syndrome 
x Laurence-Moon-Biedl syndrome 
x Cushing's syndrome 
x Hypothyroidism. 
x Insulinoma 
x Craniopharyngioma and other disorders involving the hypothalamus 
Pathologic Consequences of Obesity 
  Obesity has major adverse effects on health. Obesity and overweight 
together are the second leading cause of preventable death in the United 
States. Mortality rates rise as obesity increases, particularly when obesity is 
associated with increased intraabdominal fat[12]. 
 Obesity is associated with an increase in mortality: 
x 50–100% increased risk of death from all causes compared to normal-
weight individuals, mostly due to cardiovascular causes[13]. 
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x   Life expectancy of a moderately obese individual could be shortened 
by 2–5 years, and 
x A  20- to 30-year-old male with a BMI >45 may lose 13 years of 
life[27].  
Insulin resistance and type 2 diabetes mellitus 
 Hyperinsulinemia and insulin resistance are pervasive features of 
obesity, increasing with weight gain and diminishing with weight loss Obesity 
is a major risk factor for diabetes, and as many as 80% of patients with type 2 
diabetes mellitus are obese[14]. Weight loss and exercise, even of modest 
degree, increase insulin sensitivity and often improve glucose control in 
diabetes. 
Reproductive disorders 
 Disorders that affect the reproductive axis are associated with obesity in 
both men and women. Male hypogonadism is associated with increased 
adipose tissue, often distributed in a pattern more typical of females. In men 
whose weight is >160% ideal body weight (IBW), plasma testosterone and sex 
hormone–binding globulin (SHBG) are often reduced, and estrogen levels are 
increased .Gynecomastia may be seen. 
 Obesity has long been associated with menstrual abnormalities in 
women, particularly in women with upper body obesity[15,16]. Most obese 
women with oligomenorrhea have the polycystic ovarian syndrome (PCOS), 
with its associated anovulation and ovarian hyperandrogenism; 40% of women 
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with PCOS are obese. In obese women with PCOS, weight loss or treatment 
with insulin-sensitizing drugs often restores normal menses. 
  The increased conversion of androstenedione to estrogen, which occurs 
to a greater degree in women with lower body obesity, may contribute to the 
increased incidence of uterine cancer in postmenopausal women with obesity. 
Cardiovascular disease 
 Obesity is an independent risk factor for the  incidence of 
cardiovascular disease including Hypertension  coronary disease, stroke, and 
congestive heart failure (CHF) in men and women[17]. 
  With the additional effects of hypertension and glucose intolerance 
associated with obesity are included, the adverse impact of obesity is even 
more evident. The effect of obesity on cardiovascular mortality in women may 
be seen at BMIs as low as 25. Obesity, especially abdominal obesity, is 
associated with an atherogenic lipid profile.  
Hepatobiliary disease 
 Obesity is frequently associated with the common disorder 
nonalcoholic fatty liver disease (NAFLD). This hepatic fatty infiltration of 
NAFLD can progress in a subset to inflammatory nonalcoholic steatohepatitis 
(NASH) and more rarely to cirrhosis and hepatocellular carcinoma[18]. 
  Steatosis has been noted to improve following weight loss, secondary 
to diet or bariatric surgery[19].  
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Cancer 
 Obesity in males is associated with many cancers, including cancer of 
the esophagus, colon, rectum, pancreas, liver, and prostate[20]. 
 Obesity in females is associated with higher mortality from cancer of 
the gallbladder, bile ducts, breasts, endometrium, cervix, and ovaries. 
  Some of the latter may be due to increased rates of conversion of 
androstenedione to estrone in adipose tissue of obese individuals. Other 
possible mechanistic links are other hormones whose levels are linked to 
nutritional state, including insulin, leptin, adiponectin, and IGF-1. 
  It has been estimated that obesity accounts for 14% of cancer deaths in 
men and 20% in women in the United States. 
Bone and joint  
  Obesity is associated with an increased risk of osteoarthritis  and  
gout[21] 
Cutaneous disease 
The skin problems associated with obesity is 
x Acanthosis nigricans, manifested by darkening and thickening of the 
skinfolds on the neck, elbows, and dorsal interphalangeal spaces. 
Acanthosis reflects the severity of underlying insulin resistance and 
diminishes with weight loss. 
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x Friability of skin may be increased, especially in skinfolds, enhancing 
the risk of fungal and yeast infections. 
x Finally, venous stasis is increased in the obese. 
Pulmonary disease 
 Obesity may be associated with a number of pulmonary 
abnormalities[22,23,24]. These include 
x Reduced chest wall compliance 
x Increased work of breathing 
x Increased minute ventilation due to increased metabolic rate  
x Decreased functional residual capacity and expiratory reserve 
volume .  
x Severe obesity may be associated with obstructive sleep apnea and 
the  obesity hypoventilation syndrome" 
  Weight loss (10–20 kg) can bring substantial improvement, as can  
major weight loss following gastric bypass or restrictive surgery. Continuous 
positive airway pressure has been used with some success. 
Other Problems Of Obesity 
 Apart from the direct  health problem , obesity leads to many other  
problems including disadvantages in employment and increased business costs 
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there by affecting the economy of  all levels of society from individuals, to 
corporations, and also  to the government. 
BMI classification: 
WHO classification[25]: 
          1.Under weight  = BMI : <18.5 kg/m2 
          2.Normal            =  BMI :18.5 to 24.9 kg/m2 
          3 .Overweight    =   BMI :25 to 29.9 kg/m2  
          4. Obese Class 1  =  BMI :30 to 34.9 kg/m2 
          5.Obese class 2    = BMI  :35 TO 39 kg/2 
          6.Obese class 3    = BMI  :> 40 
In Asian Countries: 
       Some Asian countries including India have a higher proportion of total 
body fat and are at a greater risk of obesity related co-morbidities even at BMI 
cut-off point which are considered low risk for individuals in other 
countries[26]. 
  Hence  Asian countries propose stricter criteria for public health 
action.  
1.  Less than 18·5 kg/m2   -  underweight 
2.  18·5–23 kg/m2-   increasing but acceptable risk 
13 
3.  23–27·5 kg/m2 - increased risk 
 4. 27·5 kg/m2 or higher -   high risk 
       World Health Organization (WHO) recommends use of Body Mass 
Index (BMI) for defining obesity. BMI is the simplest and most widely used 
index of adiposity. The validity of BMI in predicting body fatness is well-
established in different age, gender and racial groups. 
 BMI has been used to predict disease like Hypertension, Stroke, 
Coronary heart disease (CHD), Type-2 diabetes mellitus (T2DM) , and some 
Cancers.BMI has also been proposed as an overall indicator of mortality as 
well . 
      To summarise  the World Health Organization (WHO)  has described 
obesity as one of the most neglected public health problems, because it affects 
every region of the world. It has  predicted  that overweight and obesity may 
soon replace more traditional public health problems such as under nutrition 
and infectious diseases as the most significant cause of poor health[29]. 
Obesity is a public health problem and policy problem because of its 
prevalence, costs, and health effects on the people . 
 Obesity has reached epidemic proportions in India in this  21st century, 
with morbid obesity affecting 5% of the country's population.  Obesity in 
children and adolescents is gradually becoming a major public health problem 
in India .  
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         According to a study published in the noted journal Lancet, India is just 
behind US and China in this global  list of top 10 countries with highest 
number of obese population. Unhealthy, processed food has become easily 
available following India's  economic liberalisation. This, combined with 
rising middle class income groups and Sedantary life style changes contribute 
to the rapidly rising level of Obesity in India. Unless we take concrete steps to 
reduce obesity at this stage we will have to face the catastropic effects of  
obesity in the future[30] 
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PULMONARY  FUNCTION TESTS ( PFT ) 
 PFT is a general term used to indicate a battery of  Pulmonary 
functions. PFT include simple screening spirometry, formal lung volume 
measurement, diffusing capacity for carbon monoxide, and  arterial blood 
gases[31]. 
 Pulmonary function tests permit accurate, reproducible assessment of 
the functional state of the respiratory system and allow quantification of the 
severity of disease, thereby enabling early detection as well as assessment of 
the natural history and the response to therapy With the great advances in 
pulmonary physiology and medical instrumentation that have occurred during 
the past 40 years, pulmonary function testing has come to assume a central 
place in the practice of pulmonary medicine Testing equipment, patient testing  
maneuvers  and  techniques have been widely standardized throughout the 
world by the efforts of professional societies. Widely accepted norms and  
parameters have  been established[32]. Of all these tests the most commonly 
used lung function screening study  is Spirometry. 
Spirometry: 
 Spirometry is a physiological test that measures how an individual 
inhales or exhales volumes of air as a function of time. 
 Spirometer was invented by   John hutchinson 
 Spirometry is an important  screening test of general respiratory health 
in the same way that blood pressure gives important information about general 
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cardiovascular health. However, on its own, spirometry does not provide  
clinicians  an aetiological diagnosis directly. 
 Spirometry  should be the clinician's first option, with other studies 
being reserved for specific indications. Most of the people can easily perform 
spirometry when trained  by an appropriate technician or other health care 
provider. This test can be done in the hospital inpatient setting, ambulatory 
setting, physician's office or in  emergency department. 
 There are two types of Lung Function  studies. They are the 
measurement of  Static Lung functions  and  Dynamic Lung functions.  
x Static Lung Function Tests measures purely volume based tests like  
Vital capacity (VC ), Inspiratory Capacity ( IC ), Inspiratory Reserve 
Volume ( IRV), Expiratory Reserve Volume   (ERV ), Residual 
Volume ( RV) and Functional Residual Capacity( FRC). 
x Dynamic Lung Function Tests measures   Flow and Time based 
parameters like Forced Vital Capacity ( FVC), Forced Expiratory 
Volume in 1 second( FEV1),Forced Expiratory Flow ( FEF 25 -75%), 
and Peak Expiratory Flow Rate( PEFR). 
 Static Lung Volumes like Residual Volume , Functional Residual 
Capacity and Total Lung Capacity can be measured by 
x Nitrogen washout technique 
x Helium dilution method 
x Body plethysmography 
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 Dynamic Lung Functions like  FVC, FEV1, FEF25-75 and PEFR can 
be easily measured by simple digital Spirometers.Spirometer can not measure 
– FRC, RV and  TLC 
Indications: 
 There are several reasons for performing spirometry[33]:  
          It can be used for diagnosing diseses  monitoring respiratory signs and 
symptoms, for preoperative risk assessment, and as a tool in research and 
epidemiologic studies. 
 The following are some of the indications : 
 1.  In any potentially hazardous occupation, individual workers 
should be monitored periodically by spirometry to detect and quantitative 
evidence of pulmonary problems.  
 2.  Spirometry appears to be the best method to identify smokers at 
risk of developing severe chronic airflow obstruction.  
 3.  Spirometry can indicate the statistical risk of specific surgical 
procedures for a group of patients..  
 4.  Many government agencies (e.g., the Social Security 
Administration) require results of spirometry to quantitate impairment in 
patients who claim disability caused by chronic bronchitis or emphysema, as 
well as pneumoconioses, pulmonary fibrosis, and other pulmonary disorders.  
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 5.  Spirometric results, including peak flow rates, are extremely 
useful in assessing the effectiveness of treatment in asthmatic patients. These 
simple tests are equally valuable for quantitating the effects of treatment in 
patients with other forms of chronic airflow obstruction, as well as many 
forms of restrictive disorders.  
 6.  Spirometry can be very sensitive to evaluate progression of 
disease, especially if baseline values, or results obtained early in the course of 
the illness, are available for comparison. This is because the variation in the 
range of normal is so large that changes in serial tests are much more sensitive 
than a single value for detecting abnormal function.  
 7.  Spirometry is an excellent screening test for detection of chronic 
airflow obstruction but may also be useful in detecting restrictive disorders.  
 8.  Spirometry should be part of the baseline clinical evaluation in 
all adult patients. If this baseline test is abnormal or if the patient has certain 
risk factors, the test should be repeated regularly (every 1 to 5 years ) 
          9.        Spirometry is used to assess patients as part of a rehabilitation 
program Medical and Industrial setup. 
          10..   In  Public health it is useful in 
     -  Epidemiological  surveys 
           - Comparison of health status of people  living in different 
environments 
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           -  Validation of subjective complaints in occupational or 
environmental settings 
           -  Derivation of reference equations 
Contraindications[34]: 
• Recent Myocardial Infarction within 1 month or  Unstable 
angina 
• Recent eye surgery 
• Active hemoptysis 
• Pneumothorax   
• Thoracic , abdominal and cerebral aneurysms 
Spirometer: 
   
 A spirometer, is an instrument which directly measures the volume of 
air  that is displaced or which  measures airflow by a flow-sensing device, 
such as a pneumotachometer or a tube containing a fixed resistance to flow.  
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 Most clinical pulmonary function testing laboratories now a days  use a 
microprocessor-driven pneumotachometer to measure air flow directly and 
then to mathematically derive volumes. 
 Types of Spirometers: 
Volume type 
x Bellows 
x Rolling seal 
x Water 
x Dry 
 
Flow Sensing (Pneumotachometer) 
x Fleisch 
x Hot-wire 
x Screen 
x Turbine 
Spirometer Quality control: 
 The American Thoracic Society has taken  great effort to standardize 
and publish detailed recommendations regarding  use of spirometry and  lung 
volumes. These guidelines are inclusive of  the selection of equipment, 
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important technical considerations  and standardization between laboratories 
for the procedures[35]. 
  The following table summarizes equipment quality control as the 
recommendations given by the American Thoracic Society[36]. 
Spirometer  Quality Control Summary: 
Test Minimum Interval Action 
Volume Daily 3-L syringe check 
Leak Daily 3 cm H2O constant pressure for 1 min 
Linearity Quarterly 
Weekly (flow 
spirometers) 
1-L increments with a calibrating syringe 
measured over the entire volume range (flow 
spirometers simulate several different flow 
ranges) 
Time Quarterly Mechanical recorder check with stopwatch 
Software New versions Log installation date and perform test using 
known subject 
 
Spirometer  performance standard 
 The summary of the suggested performance standards for an office 
spirometer[37] is given below. 
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Performance Standards for a Spirometer 
1.  A volume spirometer should: 
 Accumulate volume for greater than 30 sec 
 Accommodate volumes of up to 7 L 
 Be accurate to within 3% or 50 mL of a test volume 
2.  A flow-sensing spirometer should: 
 Be able to measure flows up to 12 L/sec 
 Be accurate to within 5% or 0.2 L/sec 
3.  Both need: 
Regular maintenance 
 Routine checks of accuracy of the spirometer and the computer 
Spirogram: 
 A spirogram is a graphic representation of bulk air movement  which is 
depicted as a volume-time tracing or as a flow-volume tracing.  
 Values generated from a simple spirogram provides the  important 
graphic and numeric datas  regarding the mechanics of the lungs, including 
airflow (Forced Expiratory Volume in 1 second ( FEV1 ) along with other 
timed volumes) and exhaled lung volume Forced Vital Capacity (FVC ) 
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  The measurement is  expressed in liters for volumes or in liters per 
second for flows and is corrected for body temperature and pressure of gas 
(BTPS) that is saturated with water vapor. 
Acceptability and Reproducibility Criteria for Spirograms: 
 The American Thoracic Society standardization guidelines for 
acceptability and reproducibility criteria are given below[38].  
  A well-trained PFT technician usually coaches the patient through the 
session until the demonstrated reproducibility of key parameters suggests the 
results represent the best possible measure of lung function at that time. 
A.   Acceptability Criteria 
1. Free from :  
x Artifacts 
x Cough or glottis closure during the first second of exhalation 
x Early termination or cutoff 
x Variable effort 
x Leak 
x Obstructed mouthpiece 
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2. Good start 
x Extrapolated volume is <5% of FVC or 0.15 L, whichever is 
greater or 
x Time to PEF is <120 ms (optional until further information is 
available) 
3. Satisfactory exhalation 
x 6 sec of exhalation and/or a plateau in the volume-time curve or 
x Reasonable duration or a plateau in the volume-time curve or 
x The subject cannot or should not continue to exhale 
B.    Repeatability Criteria 
 After three acceptable spirograms have been obtained, apply the 
following tests. 
x Are the two largest FVCs within 0.2 L of each other? 
x Are the two largest FEV1s within 0.2 L of each other? 
If both of these criteria are met, the test session may be concluded. 
 If both of these criteria are not met, continue testing until: 
x Both of the criteria are met with analysis of additional acceptable 
spirograms or 
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x A total of eight tests have been performed or 
x Save a minimum of three best maneuvers 
Procedures for recording forced vital capacity: 
x Check the spirometer calibration 
x Explain the test 
x Prepare the subject 
x Ask about smoking, recent illness, medication use, etc. 
x Measure weight and height without shoes  
x Wash hands 
 Instruct and demonstrate the test to the subject  
x to include Correct posture with head slightly elevated 
x Inhale rapidly and completely 
x Position of the mouthpiece (open circuit) 
x Exhale with maximal force 
 Perform manoeuvre (closed circuit method) 
x Have subject assume the correct posture 
x Attach nose clip, place mouthpiece in mouth and close lips around 
the mouthpiece 
x Inhale completely and rapidly with a pause of ,1 s at TLC 
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x Exhale maximally until no more air can be expelled while 
maintaining an upright posture 
x Repeat instructions as necessary, coaching vigorously 
x Repeat for a minimum of three manoeuvres; no more than eight are 
usually required  
x Check test repeatability and perform more manoeuvres as necessary 
 Perform manoeuvre (open circuit method) : 
x Have subject assume the correct posture 
x Attach nose clip  
x Inhale completely and rapidly with a pause of ,1 s at TLC 
x Place mouthpiece in mouth and close lips around the mouthpiece 
x Exhale maximally until no more air can be expelled while 
maintaining an upright posture 
x Repeat instructions as necessary, coaching vigorously 
x Repeat for a minimum of three manoeuvres; no more than eight are 
usually required 
x Check test repeatability and perform more manoeuvres as necessary 
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QUALITY OF THE DATAS: 
 The quality of the datas are assessed by  two graphs called the 
x Volume-Time Tracing and  
x Flow-Volume Loop     
The Volume-Time is most useful in assessing whether the end of test 
criteria have been met  whereas   The flow-volume loop is most valuable in 
evaluating the start-of-test criteria[39] 
 These graphs ascertain : 
x the technical adequacy of a procedure 
x  the quality of the data 
x the anatomic location of airflow obstruction 
Volume-Time curve : 
 
Volume-Time Graph 
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 In Volume-Time graph X- axis is represented by Time in seconds and 
Y – axis is represented by Volume in litres. FEV1-Forced Expiratory Volume 
in 1 second is the volume expired in the first second of the FVC test and is a 
very important parameter in spirometry.This parameter is measured from 
Volume-Time graph. 
 In the following graph the morphology of Volume-Time graph seen in 
normal sujects ,patients with Obstructive lung disease and and in Restrictive 
lung diseases are given[40] 
 
                         A healthy patient can expire  about 80% of all the air out of his 
lungs in the first second during the FVC maneuver. A patient with  
Obstruction of the upper airways takes longer time to expire all the air from 
his lungs.The Volume expelled air in 1 second will be less in Obstructive 
Lung  diseases and there by causes a decreased FEV1/FVC ratio. 
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 A FEV1% that is too high is suggestive for a Restriction of the 
pulmonary volume. 
 After 6 seconds a second parameter can obtained- FEV6. This can been 
used as an alternative for FVC.  FEV1/FEV6 can than be used in stead of 
FEV1/FVC[42]. 
Flow-Volume loop : 
                              
                                         Flow-Volume Loop 
 The flow-volume loop is the most important graph in spirometry.This 
flow-volume loop is most valuable in evaluating the start of test criteria[43]. 
 A Flow-Volume loop begins at the intersection of the X-axis (volume) 
and Y-axis (flow) At the start of the test both flow and volume are equal to 
zero. Directly after this starting point the curve rapidly mounts to a peak. This 
is the  Peak Expiratory Flow. If the test is performed correctly, this PEF is 
attained within the first 150 milliseconds of the test.  
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 It is important to note that as there is no time axis on the flow-volume 
loop , one can not interpret time intervals. A healthy patient  expires between 
70 and 90% of the FVC in the first second of the test. This means that it takes 
roughly about 5 seconds for him to expire the last 10 to 30 % of the FVC. The 
point where the FEV1 is reached is shown on the curve as an illustration. 
 When the flow reaches zero, the FVC is reached . This is the Forced 
Vital Capacity and the patient has blown out as much air as he can. 
 After this the patient makes a complete and forced inspiration to obtain 
a closed flow-volume loop  but the test can be interpreted without this as 
well[44]. 
The morphology of the flow-volume loop  
       The morphology of the flow-volume loop is very important. For  the 
trained eyes  the flow-volume loop tells immediately if the test was well done . 
From the shape of the flow-volume loop  one can easily find  the location of 
airflow limitation, such as the large upper airways or smaller distal 
airways[45]. 
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A. Normal flow-volume loop: 
 
Normal Flow-Volume Loop 
 The normal  Flow-Volume loop begins on the X-axis – also called 
Volume axis  at the start of the test where  both flow and volume are equal to 
zero. After a starting point this curve rapidly mounts to reach a a peak which is 
called  Peak Expiratory  Flow[46]. 
 After the Peak Expiratory Flow, the curve descends and the flow 
decreases as more air is expired. A normal,  Flow Volume loop  descends in a 
straight or a convex line from top (PEF) to bottom (FVC). 
 The forced inspiration that follows the forced expiration has roughly 
the same morphology, but the PIF (Peak Inspiratory Flow) is not as distinct as 
PEF.  
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B. Obstructive Lung Disease: 
 
Flow-Volume Loop in Obstructive Lung Disease 
 If the flow-volume loop is concave  as seen in the above picture  a 
bronchial obstruction can be suspected (Diseases like COPD or Bronchial 
Asthma) [47]. 
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C.  Restricive disorders: 
 
Flow-volume Loop in restriction  lung disease 
  The airways are normal hence the flow volume loop will be  normal in 
shape. The curve will descend in a straight line from the PEF to the X-axis. 
The total lung volume is low, which results in a low FVC. PEF can be normal 
or low. 
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D.   Mixed Lung Disease: 
 
Flow-Volume Loop of Mixed Lung diseases 
 
 Some times  patients will show signs of both obstructive and restrictive 
lung disease. The flow-volume loop will have the  characteristics of both 
diseases. 
Parameters of Spirometry: 
 Results of the Spirometry  are usually given in both absolute 
values(litres, litres per second) and “ percent predicted”—the test result as a 
percent of the "predicted values" for the patients of similar characteristics 
(height, age, sex, and sometimes race and weight). The following parameters 
are derived from the Spirometry[48] : 
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1.  Forced Vital Capacity: 
 Forced vital capacity (FVC) is the volume of air that can forcibly be 
exhaled out after full inspiration, measured in liters. 
  FVC is the most basic paramrter in spirometry tests.The results 
obtained  are compared to the predicted values that are calculated from his 
age, size, weight, sex and ethnic group[49]. 
 FVC is usually decreased in diseases that cause the lungs to be smaller. 
In other words a decreased VC reflects limitation in chest excursion.Such 
processes are seen in  Restrictive  lung diseases[50]. 
Examples: 
x  Disorders of the lung parenchyma such as Pulmonary fibrosis  
x Disorders of the bellows including Kyphoscoliosis, 
x  Neuromuscular disease, 
x  Pleural effusion 
  However, a reduction in FVC  may  not always be due to reduced  total 
volumes .It is not a reliable indicator of total lung capacity or restriction, 
especially in the setting of airflow obstruction[51]. 
Examples: 
x Bronchial Asthma 
x COPD  
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2.  Forced Expiratory Volume in 1 Second FEV1: 
 FEV1 is the volume of air that can forcibly be exhaled  in one second, 
after full inspiration. The FEV1 is the most widely used parameter to measure 
the mechanical properties of the lungs. The results of the test are compared to 
the predicted values that are calculated from his age, size, weight, sex and 
ethnic group[52]. 
  In normal persons, the FEV1 accounts for the greatest part of the 
exhaled volume from a spirometric maneuver and it reflects mechanical 
properties of the airways of  both  large and the medium size[53]. 
  In a normal flow-volume loop, the FEV1 occurs at about 75% to 85% 
of the FVC[54]. This parameter is reduced in obstructive and restrictive 
disorders. 
x In Obstructive Lung diseases FEV1 is reduced disproportionately to the 
FVC, thereby reducing the FEV1/FVC ratio below the lower limit of 
normal.This indicates airflow limitation. 
x In Restrictive Lung  diseases  FEV1, FVC and total lung capacity are all 
reduced and the FEV1/FVC ratio is normal or even elevated. 
3.  Additional Tests 
 A variety of parameters selectively reflect small airways. These include 
measures of flow from a spirogram, such as MMEF-  the maximal mid 
expiratory flow or  FEF25-75   -  the forced expiratory flow at 25% to 75% of 
vital capacity[55]  
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 The FEF25-75 is the slope of the spirogram between the 25th and the 
75th percentiles of an FVC maneuver. Normal values and lower limits of 
normal for the FEF25-75% have been published.  A  new parameter to assess 
small airways function - the FEV3/FVC ratio, are proposed but this parameter 
is  yet to  be sufficiently validated[56]. 
Normality and predicted equations: 
 Studies  conducted from  healthy population indicate that the 
parameters of lung function, such as FEV1 or FVC, are affected most 
significantly by  height, age, gender, race, and   weight[57].   
 Over the years, many regression equations have been generated by 
several investigators using different methodologies to study a variety of 
populations. The most commonly used standards are those of Morris and 
colleagues,  Crapo and colleagues, Knudson and colleagues  and the National 
Health and Nutrition Examination Survey (NHANES II)[58]. These reference 
standards are based on a cohort of normal subjects of similar age, height, and 
race, with normal being defined as persons without a history of smoking or 
disease that can affect lung function. 
 Many approaches have been developed to determine the normal range 
of spirometry. The American Thoracic Society recommends using the concept 
of lower limit of normal by identifying the lowest 5% of a population, or 
patients that fall outside the limits of 1.645 standard deviations from the mean. 
 This value may be calculated by multiplying 1.645 times the standard error of 
estimate (1.645 × SEE)[59]. 
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Clinical interpretative strategies: 
 The respiratory diseases can be classified as obstructive or 
restrictive processes.  
Obstructive disorders: 
 These are characterized by 
x Airflow limitation 
x Increased lung volumes with air trapping 
x Normal or increased compliance (based on pressure volume profile) 
 Restrictive disorders 
 These are characterized by 
x Reduced lung volumes and  
x  Increased  overall stiffness of the lungs (with reduced compliance). 
  The summary the common obstructive and restrictive lung diseases[62] 
are given below. 
Common Restrictive and Obstructive Lung Diseases 
x Common Obstructive Lung Diseases 
x Bronchial Asthma 
x Chronic obstructive pulmonary disease  which includes chronic 
bronchitis, emphysema and the overlap between them) 
x Cystic fibrosis 
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Common Restrictive Lung Diseases 
Interstitial Lung Diseases 
x Idiopathic pulmonary fibrosis 
x Interstitial pneumonitis 
x Sarcoidosis 
x Pneumoconiosis  etc 
Congestive heart failure 
x Infectious inflammation (e.g., histoplasmosis, mycobacterium 
infection) 
x Neuromuscular diseases 
x Chest wall deformities like Kyphoscoliosis 
Interpretation: 
 Generally, the measured values are compared with the lower limits of 
normal predicted values which are already calculted from the published 
studies  and the results are interpreted as follows[60]: 
Obstructive Lung diseases : 
x The FEV1 /  FVC ratio  is reduced  below the lower limits of normal. 
Restrictive  Lung diseases : 
x The FEV1 / FVC ratio is normal but the FVC is reduced below lower 
limits of normal. 
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Mixed Abnormality: 
x The FEV1 / FVC ratio is reduced  below the lower limits of normal and  
x The FVC is also reduced below lower limits of normal. 
The  assessment of severity of obstruction and restriction are given 
below which follows the American Thoracic Society's criteria for grading the 
severity of lung function abnormality[61]. 
 Normal  
x Both the VC and the FEV1/VC ratio are in the normal ranges 
 Severity of Obstruction Abnormality 
x May be a physiologic variant: Predicted FEV1 100% 
x Mild: Predicted FEV1 <100% and 70% 
x Moderate: Predicted FEV1 <70% and 60% 
x Moderately severe: Predicted FEV1 <60% and 50% 
x Severe: Predicted FEV1 <50% and 34% 
x Very severe: Predicted FEV1 <34       
 Severity of Restriction abnormality 
x Mild: Predicted  FVC < LLN but 70% 
x Moderate: Predicted  F VC <70% and 60% 
x Moderately severe: Predicted  FVC <60% and 50% 
x Severe: Predicted  FVC <50% and 34% 
x Very severe: Predicted   FVC <34        
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Flow chart- An approach to spirometry Interpretation:  
A flow Chart on the approach to the interpretation of spirometry is given 
below[63].The explanation is already discussed in the previous pages. 
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MATERIALS AND METHODS 
 
PLACE OF STUDY:  
    Chengalpattu Medical College Hospital, Chengalpattu. 
DURATION OF STUDY :  
     15 months ( June 2014 –August  2015)  
POPULATION  STUDIED :  
      300 (both males and females) 
STUDY GROUP: 
         Above the age of 15 years of  apparently healthy individuals attending 
Master Health Check Up OP  and  attenders of in-patients of wards of general 
medicine department, Govt. Chengalpattu Medical College, Chengalpattu. 
INCLUSION CRITERIA: 
 All apparently healthy individuals of either gender above the age of 15 
years of age . 
EXCLUSION CRITERIA: 
1. Smokers both Current and  Ex-smokers and other tobacco users in any 
other form (chewing, snuffing or water pipe) were excluded from our 
study. (Ex-smoker is defined as someone who has smoked more than 
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100 cigarettes in his lifetime, does not currently smoke, but used to 
smoke daily previously) 
2.  Subjects with pre-existing pulmonary (e.g. tuberculosis, bronchial 
asthma, COPD etc.) disease. (By careful history taking and subjects 
with any chest symptoms like cough ,cold, Breathing difficulty, chest 
pain etc were excluded from the study) 
3. Other systemic conditions (e.g. diabetes mellitus, hypertension, etc.) 
were also excluded. 
x  Blood pressure was checked for all the patients. Subjects with high 
Blood pressure  or   any past history of high  BP were excluded. 
x Random Blood sugar was checked for all subjects. Subjects with high 
blood sugar values of above 140 mgm% and past history of high blood 
sugsar were excluded from the study. 
METHODS:   
 Proper approval for this study was obtained from Instituitional Ethical 
Committee of Chengalpattu Medical College. Written informed consent was 
obtained from each participant prior to inclusion in the study. 
  Anthropometric measurements have been done by standard techniques 
.To ensure correct measurement of height,subjects were asked to straighten 
their back and observer adjusted the head of the subject in Frankfort plane. 
Weight was measured by a electronic weighing scale. Subjects removed shoes 
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before measurement of height and weight. BMI was calculated as kg/m2 from 
height and weight.  
 BMI was used as a measure of obesity and subjects were classified  into 
five  categories as follows :  
         1.Under weight  = BMI : <18.5 kg/m2 
          2.Normal            =  BMI :18.5 to 24.9 kg/m2 
          3 .Overweight    =   BMI :25 to 29.9 kg/m2  
          4. Obese Class 1  =  BMI :30 to 34.9 kg/m2 
          5.Obese class 2    =  BMI  :35 TO 39 kg/2 
           Dynamic lung functions were measured by spirometry.We used a flow 
measuring type digital spirometer (Spirolab III, Version 3.7, Rome, Italy). 
Measurements were done in accordance with the latest joint American and 
European guidelines which have replaced the older ATS and ERS guidelines 
respectively. All recordings were made between 09:00 AM and 12:00 PM to 
avoid any presumed diurnal variations. 
   Subjects were instructed regarding the correct way of blowing air into 
the spirometer and taking a deep breath before forceful expiration prior to the 
test. Spirometry of all subjects was done in proper sitting position for 
standardization and uniformity in interpretation of results. Nose clip was 
applied to all participants to avoid air leakage from nasal passages. A new 
disposable mouth-piece was attached to the spirometer before testing each 
participant. It was ensured that subjects sealed their lips tightly around the 
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mouth-piece and blew out air as hard and fast as possible. The subject was 
actively encouraged during the procedure to breathe out as long as possible. 
  Tests were discarded and repeated if subjects coughed or blocked the 
meter with their tongue. Test was repeated for three recordings that met the 
acceptability and reproducibility criteria and the highest reading was reported. 
The procedure was abandoned if a participant was unable to produce an 
acceptable and repeatable spirogram after 8 attempts. 
Dynamic lung volumes were assessed as 
1. FVC (measured in litres)  and FVC % reported as percentage of 
predicted values 
2. FEV1 (measured in litres)  and FEV1 %  reported as percentage of 
predicted values  and 
3. Ratio of FEV1 to FVC (FEV1/FVC % ).  
 Lung volumes were reported as percentage of predicted value as a 
linear variable possibly corrected  for the effects of age and gender.  FVC %  
and  FEV1 % were calculated by the following  equation : 
x FVC % = measured FVC / reference value for FVC x 100 
x FEV1 % = measured FEV1 / reference value for FEV1 x 100 
ANALYSIS:   
 Analysis has  been done  by comparing the groups using   t-test  and 
ANOVA.  Correlation is assessed by Pearson’s r method 
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RESULTS AND ANALYSIS 
 
There are 300 participants in this study.The information was collected 
prospectively. The demographic profile of the participants along with 
pulmonary function test were collected and entered in to MS Excel sheet and 
analyzed by using SPSS 16.0V. One way ANOVA and Chi sq test are used to 
find the significance among the Pulmonary functions at 5% level of 
significance. 
Demograpic Profile: 
Table 1 : Gender distribution of participants: 
Sex No.of participants % 
Male 244 81.3% 
Female 56 18.7% 
Total 300 100 
 
 This table  shows that 300 people participated in our study. Out of these 
244 are males constituting 81.3% of our study  population.The remaining 56 
are females thus constituting 18.7% of our study population. 
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Table : Age distribution of  Participants 
Age No. of participants % 
10.-20 21 7% 
21-30 62 20.7% 
31-40 71 23.7% 
41-50 86 28.7% 
51-60 50 16.7% 
61-70 8 2.7% 
>70 2 0.7% 
Total 300 100 
 
 People above the age of 10 years were selected for the study.This table 
shows that most of the participants are from 31 to 50 years age group. 
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Table  3  :  BMI distribution of participants 
BMI No.of participants % 
Under weight 10 3.3 % 
Normal 111 37 % 
Over Weight 114 38 % 
Class I Obesity 58 19.3 % 
Class II Obesity 7 2.3 % 
Total 300 100 
 
The Body mass index was classified by international BMI 
classification.Most of the people are either over weight or obese. The median 
BMI is over weight in our study area. Very few participants fall in class II and 
no one is in class III obese.  
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Table 4: Age Distribution over BMI 
Age Under weight Normal 
Over 
Weight 
Class I 
Obesity 
Class II 
Obesity Total 
Chi 
sq p 
10.-
20 8 (80%) 10(9%) 2 (1.8%) 1 (1.7%) 0 21 
10.9 0.0001 
21-30 1 (10%) 29 (26.1%) 
21 
(18.4%) 11 (19%) 0 62 
31-40 0 22 (19.8%) 
31 
(27.2%) 17 (29.3%) 1 (14.3%) 71 
41-50 1 (10%) 34 (30.6%) 
29 
(25.4%) 17 (29.3%) 5 (71.4%) 86 
51-60 0 12 (10.8%) 
25 
(21.9%) 12 (20.7%) 1(14.3%) 50 
61-70 0 3 (2.7%) 5 (4.4%) 0 0 8 
>70 0 1 (0.9%) 1 (.9%) 0 0 2 
Total 10 111 114 58 7 300 
 
 This study  shows that 14% of people are overweight or obese in 11 - 
20 years age group whereas it increased to 76% in  51 - 60 age groups 
respectively thus  indicating that as age increases people  tend to become 
overweight or obese . The association between the variables are found by chi 
sq = 10.9 with p = 0.0001 which is significant.   
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Graph1 : Age Distribution over BMI 
r 
This graph also shows that as age increases  more and more people are 
becoming overweight or obese. The association between the variables are 
found by chi sq = 10.9 with p = 0.0001 which is significant.  
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Table 5: Mean Age Distribution across  BMI 
AGE No. Mean Age Std. Deviation F Sig. 
Under weight 10 20.8 8.443 
8.836 0.0001 
Normal 111 37.68 12.669 
Over Weight 114 41.89 11.918 
Class I Obesity 58 40.07 10.052 
Class II Obesity 7 46.29 8.46 
Total 300 39.38 12.322 
 
 This table shows that as age increases people  tend to become 
overweight or obese.  The Mean age of the underweight is 20.8  years and it 
increased  to 46.29 years  in  Class II Obesity.  
  This classification found significance by one way ANOVA F = 8.836, 
P = 0.0001 
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Graph 2: Mean Value of Age across BMI 
    
 This graph describes the mean age of participants in each  BMI 
category. The Mean age of the underweight is 20.8  years and it increased  to 
46.29 years  in   Class II Obesity. This classification found significance by one 
way ANOVA F = 8.836, P = 0.0001 
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Table 6: Sex distribution over BMI 
Sex Under weight Normal 
Over 
Weight 
Class I 
Obesity 
Class II 
Obesity Total 
Chi 
sq p 
Male 7 (70%) 
89 
(80.2%) 
98 
(86%) 
46 
(79.3%) 
4 
(57.1%) 244 
5.4 0.2 Female 3 (30%) 
22 
(19.8%) 
16 
(14%) 
12 
(20.7%) 
3 
(42.9%) 56 
Total 10 111 114 58 7 300 
 
 There is no significant difference in BMI between male and female 
participants. The chi sq value 5.4, p = 0.2 
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Graph  3: Sex Distribution 
 
 This Table shows that there is no significant difference in BMI between 
male and female participants. The chi sq value 5.4, p = 0.2 
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Graph 4 : Mean value of  FVC  in Litres across  sex distribution 
 
 This graph shows that the absolute values of  mean FVC  is  
significantly high in  Males in each BMI group. 
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Graph 5 : Mean value of FVC % across sex distribution 
 
Graph 6 : Mean value of FEV1 in Litres across sex distribution  
 
 This graph shows that the absolute values of  mean FEV1  is  
significantly high in  Males in each BMI group 
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Graph 7 : Mean value of  FEV1 % across sex distribution 
 
 
Graph 8 : Mean value of FEV1 /  FVC  % across sex distribution 
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Table 7 : Mean Distribution of FVC (%) across BMI 
FVC % N Mean Std. Deviation F Sig. 
Under weight 10 93.4 8.796 
11.906 
 
0.0001 
 
Normal 111 95.93 10.031 
Over Weight 114 91.07 9.585 
Class I Obesity 58 85.1 12.02 
Class II Obesity 7 82.14 17.967 
Total 300 91.58 11.204 
 
 This Table describes that the normal group mean value of FVC (%) 
ranges from 95.93 + 10.03 and  it is decreasing up to 10% to 12% when they 
become obese. Obese   participants (BMI > 30 kg/m2) have significantly 
lower values of FVC%   when compared to participants of  normal BMI < 25 
kg/m2  ( Obese class I : 85.1 +_ 12 and Obese class II : 77.8 +_15.2  vs 
Normal:  95.9+_ 10 ).  The significant difference calculated by using One Way 
ANOVA F = 11.9 with p = 0.0001. 
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Graph 9 : Bar diagram Mean Distribution of FVC (%) across BMI 
 
 
 This graph describes that the normal group mean value of FVC (%) 
ranges from 95.93 + 10.03 and  it is decreasing up to 10% to 12% when they 
become obese. Obese   participants (BMI > 30 kg/m2) have significantly 
lower values of FVC%   when compared to participants of  normal BMI < 25 
kg/m2  ( Obese class I : 85.1 +_ 12 and Obese class II : 77.8 +_15.2  vs 
Normal:  95.9+_ 10 ).  The significant difference calculated by using One Way 
ANOVA F = 11.9 with p = 0.0001. 
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Table 8 : Mean Distribution of FEV1 (%) across BMI 
FEV1 % N Mean Std. Deviation F Sig. 
Under weight 10 93.5 9.419 
6.464 
0.0001 
 
Normal 111 94.89 10.891 
Over Weight 114 92.12 9.708 
Class I Obesity 58 87.12 11.792 
Class II Obesity 7 82.43 15.884 
Total 300 92 11.111 
 
 This table  describes that the normal group mean value of FEV1 (%) 
ranges from 94.89 + 10.89 and it is  decreasing up to 7% to 10% when they 
become obese. Obese  participants (BMI > 30 kg/m2) have significantly lower 
values of   FEV1% when compared to participants of  normal BMI < 25 kg/m2  
( Obese class I : 87.1 +_11.8 and Obese class II: 78.7 +_13.6  vs Normal:  94.9 
+_10.9 ). The significant difference calculated by using One Way ANOVA F 
= 6.46 with p = 0.0001. 
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Graph 10 : Bar diagram Mean Distribution of FEV1 (%) across BMI 
 
 This graph describes that the normal group mean value of FEV1 (%) 
ranges from 94.89 + 10.89 and it is  decreasing up to 7% to 10% when they 
become obese. Obese  participants (BMI > 30 kg/m2) have significantly lower 
values of   FEV1% when compared to participants of  normal BMI < 25 kg/m2  
( Obese class I : 87.1 +_11.8 and Obese class II: 78.7 +_13.6  vs Normal:  94.9 
+_10.9 ). The significant difference calculated by using One Way ANOVA F 
= 6.46 with p = 0.0001. 
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Table 9: Mean Distribution of FEV1/FVC (%) across BMI 
FEV1/FVC (%) N Mean Std. Deviation F Sig. 
Under weight 10 93.83 12.4336 
3.104 
 
0.016 
 
Normal 111 93.301 11.2256 
Over Weight 114 98.206 11.3803 
Class I Obesity 58 97.743 11.9203 
Class II Obesity 7 93.629 10.3019 
Total 300 96.049 11.6023 
 
This graph describes that the normal group mean value of FEV1/FVC 
(%) ranges from 93.3 + 11.23  and it is increasing up to 4% to 5% when they 
become obese. The significant difference calculated by using One Way 
ANOVA F = 3.104 with p = 0.016. 
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Graph 11 :  Bar Diagram Mean Distribution of FEV1/FVC (%) across 
BMI 
 
This graph describes that the normal group mean value of FEV1/FVC 
(%) ranges from 93.3 + 11.23  and it is increasing up to 4% to 5% when they 
become obese. The significant difference calculated by using One Way 
ANOVA F = 3.104 with p = 0.016. 
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Table 10 : Correlation with BMI 
BMI Correlation p value 
Age 24.40% 0.001 
FVC(%) -36% 0.001 
FEV1(%) -25.30% 0.001 
FEV1/FVC ( %) 16.70% 0.004 
 
To find the relationship between two continuous variables pearson 
correlation coefficient are used at 5% level of significance. Table 10 shows  
that there is 24.4% positive correlation between age and BMI as age increases 
people are tend become obese,p = 0.001. there is 36% negative correlation 
between FVC (%) with BMI, That implies that as BMI increases the 
percentage of FVC tend to decrease, p = 0.001. same way there is 25.3% 
negative correlation between FEV1(%) with p = 0.001. but the ration of 
FEV1/FVC(%) were tend to increase as BMI increases there is 16.7% slight 
positive correlation explained in this study with p = 0.004. 
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Graph 12 : Scatter diagram of BMI with FVC(%) 
 
 This graph explains that there is negative correlation with BMI and 
FVC (%). As BMI Increase FVC decrease. The line explains the linear 
relationship with 95% confidence interval. 
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Graph 13 : Scatter diagram of BMI with FEV1(%) 
 
 This graph explains that there is negative correlation with BMI and 
FEV1 (%). As BMI Increase FEV1 decrease. The line explains the linear 
relationship with 95% confidence interval. 
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Graph 14 : Scatter diagram of BMI with FEV1/FVC(%) 
 
 This graph explains that there is positive correlation with BMI and 
FEV1/FVC (%). As BMI Increase FEV1/FVC (%) increase. The line explains 
the linear relationship with 95% confidence interval 
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Graph 15 : Box plot of BMI classification with FVC(%) 
 
 This graph explains the descriptive statistics for each BMI classification 
across FVC (%) 
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Graph 16 : Box plot of BMI classification with FEV1(%) 
 
 This graph explains the descriptive statistics for each BMI classification 
across FEV1 (%) 
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Graph 17 : Box plot of BMI classification with FEV1/FVC(%) 
 
 This graph explains the descriptive statistics for each BMI classification 
across FEV1/FVC (%) 
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DISCUSSION 
 
1. Prevalence of Obesity: 
  In our study sample of 300,  nearly 60%  of the participants are either 
overweight or obese.This study  shows that the problem of obesity in  is 
increasing in India[66] .The results of the study conducted  by C.S.Yajnik et 
al[67] on obesity in India and National Family Health Survey 2005-2006  
showed that  Obesity   has reached epidemic proportion in  India in this 21st 
century(A,B).Our study also shows similar results.This problem is due to the 
easy access to the unhealthy high caloric  processed food , increase in the 
middle class group  following globalisation and  sedentary life style. 
2. Age and BMI :  
  Our study shows that as age increases BMI also increases[68].In this 
study  14% of  people are overweight or obese in 11 - 20 years age group 
whereas it increased to  51% and to 76% in 21 – 30  and 51 - 60 age groups 
respectively. Body weight  increased with age . The increase in body weight 
and BMI with age  has also been reported by Kapoor and Tyagi [69] and 
Tandon [70] in studies conducted in India. 
   Increase in body weight in  middle age may be due to the  
accumulation of fat with age as these subjects have larger appetite leading to 
increased energy intake, fat-rich diet, and relatively less energy expenditure 
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due to lesser involvement in physical activities due to other  family and 
professional commitments. 
3.  BMI and Gender  
Our study shows  that there is no significant  difference in distribution 
of BMI  between male and female .This is in contrast to the earlier studies. 
Lovejoy et al[71] reported that Obesity prevalence is generally higher in 
women than in men, and there is also a sex difference in body fat 
distribution.The prevalence of overweight and obesity among men and women 
varies greatly within and between countries, and overall, more women are 
obese than men. These gender disparities in overweight and obesity are 
exacerbated among women in developing countries. Sex differences in obesity 
can be explained in part by the influence of gonadal steroids on body 
composition and  appetite; however, behavioural, socio-cultural and 
chromosomal factors may also play a role. 
                In contrast to the above studies our study do not show significant 
difference in distribution of BMI  among male and and female 
population.However the percentage females participated in our study is very 
less ,only 18.7%.Probably studies with bigger sample of females may show 
more light on these ststistics. 
4. Dynamic Lung functions and BMI : 
 Our  study reports the findings of strong inverse  association between 
obesity and  lung volumes and the details are as follows:                
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 Our study shows clearly that Obese  participants have  
A. Significantly lower values of FVC%   than participants of  Normal 
BMI 
B.  Significantly lower values of   FEV1% than participants of  Normal 
BMI 
C. Significantly high ratio of  FEV1/FVC (%)  than participants of 
Normal BMI. 
 The above findings of decrease in  FVC % and FEV1 % in obese 
participants are consistent with those of some investigators who have shown 
that  lung volumes are significantly lower among subjects in higher BMI 
groups.   
 These findings are comparable with the study conducted by Sohail 
Attaur-Rasool  et al in Pakistan[72]. Moreover these results are consistent with 
results reported by  Steele et al. [73]from proactive trial in British adults 
having family history of T2DM as  well as by Morsi[82]  who studied Saudi 
adults with varying degree of  asthma and  they reported negative correlation 
of BMI  with FVC % and FEV1 % .8,21   
 Studying the same association, Al-Badr et al[74]. reported  significant 
inverse  association between BMI and both FVC% and FEV1% in obese 
subjects only.  
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             However the presence of  differences in  Lung function among BMI 
categories in our study differ from some others studies. Costa et al[75]  
reported no significant difference of FVC%, FEV1% and FEV1/FVC among 
obese and  non-obese  females in Brazil.  Chen et al[76]  detected  positive 
association of BMI with FVC and FEV1 in  normal weight Canadians but 
negative association among overweight and obese subjects.  Rasslan et al[77]  
found no significant correlation between pulmonary function and BMI among 
a  sample of Brazilians. Moreover, Koziel et al[78]  reported positive 
association of BMI with lung function among both males and females in 
Poland. 
D.  Our study shows  that gender  has   no effect on mean values of 
FVC%   and  FEV1% . 
 This is is  comparable with the earlier study done by Sohail Attaur-
Rasool  et al  in Pakistani population       
           No gender differences of baseline pulmonary  function found among 
these participants may be due to smaller sample size of  females  in our study  
and analysis of pulmonary function variables as percentage of predicted  
value.It is important to note that lung volumes reported as percentage of  
predicted value are a linear variable related to lung compliance. The proposed  
added advantage of using percent predicted values of lung function is a 
possible adjustment for the effects of age and gender on measured lung 
volumes in litres, which are affected by an individual's gender and age . 
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E.  However our study shows that the mean absolute value of FVC  in litr 
is significantly higher in Males . 
 This result is comparable with the results of the  earlier studies done by  
Harik-Khan RI et al[79] and by Sohail Attaur-Rasool et[80] al  in United 
Kingdom and  Pakistan respectively.  This gender  difference in absolute raw 
values  reported  is likely to be attributed to the fact that men tend to have 
bigger lungs for same height when compared with females.Muscularity in men 
is another contributing factor to higher values of pulmonary function among 
men. Observing the same  phenomenon, Osch-Balcom et ai[81] reported that 
raw values of  FVC and FEV1 were higher in men. 
              Association of BMI with Lung function is very diverse and 
complicated as  reported by various researchers across various populations. 
Thus the  exact nature    of difference of Lung functions  among subjects  of 
varius BMI groups and gender in different ethnic groups have been difficult to  
interpret. But our study clearly shows that Obesity and  Dynamic Lung 
Functions are inversely associated .                                  
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CONCLUSION 
 
    Our  study conducted in the sample of population who comprised of 
apparently healthy individuals of above the age of 15 years, attending Master 
Health Check Up Op  and attenders of  inpatients of wards of  general 
medicine department,Govt.  Chengalpattu Medical College, Chengalpattu  
reports the findings that increasing  BMI is strongly  associated with decreased  
lung  volumes. Larger epidemiological    studies in future may help further 
elucidate these relationships. 
 By understanding the correlation between the dynamic lung volumes 
and the BMI we would be  able to predict the longevity of the Respiratory 
capacity  of a person. Since human productivity and lung capacity are directly 
related and  obesity is the core issue of many health problems , this study can 
throw light in  formulating a public health  policy in preventing obesity.  
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 PROFORMA 
 
 
DEMOGRAPHIC DATA OF THE PATIENT: 
Name:                                                                       OP No: 
Age:                                                                          Case Serial No: 
Sex: 
Address: 
Occupation: 
HISTORY OF PRESENTING COMPLAINTS: 
Cough/ Cold/ Wheezing 
Difficulty In Breathing/ /Chest pain / Fever 
Oliguria/Dysuria/Nocturia/Haematuria 
Nausea/Vomiting/Diarrhoea 
Bilateral Swelling Of Legs/ Facial Puffiness 
PAST HISTORY: 
H/o Diabetes mellitus 
H/o Hypertension 
H/o CAD 
H/o TB/ COPD/ Bronchial asthma/ Allergic rhinitis 
PERSONAL HISTORY: 
H/o Smoking 
H/o Alcohol consumption 
FAMILY HISTORY: 
 H/O / Atopy/ Bronchial Asthma 
 GENERAL PHYSICAL EXAMINATION: 
Built/ Nutrition 
Pallor/ Cyanosis/ Clubbing 
Pedal Oedema/ Generalised Lymphadenopathy 
Skin/ Nails/ Mucous membrane 
VITAL SIGNS: 
PR-                              Height- m2 
BP-                              Weight-kg 
RR-                             BMI- kg/ m2 
JVP- 
RESPIRATORY SYSTEM: 
Inspection 
Palpation 
Percussion 
Auscultation 
CVS/ ABDOMINAL/ NERVOUS SYSTEM  EXAMINATION: 
INVESTIGATIONS: 
CBC 
RFT 
LFT 
ECG 
USG- ABDOMEN 
SPIROMETRY 
 
 
 
 KEY  TO  MASTER  CHART 
 
 
Kg Kilogram 
Cm Centimeter 
BMI Body Mass Index 
FVC Forced Vital Capacity 
Lit Litre 
FEV1 Forced Expiratory Volume in 1 Second 
% Percentage 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 MASTER CHART 
 
 
S. 
NO NAME AGE SEX 
WEIGHT 
(Kg) 
HEIGH
T (Cm) BMI 
FVC 
(Lit) FVC % 
FEV1 
(Lit) 
FEV1 
% 
FEV1/ 
FVC (%) 
1 SIDHARTH 52 M 88 163 33.1 2.94 91 2.42 92 82.3 
2 YOGA GANDHI 47 M 72 169 25.2 4.03 111 3.44 116 85.4 
3 SENTHAMIL 35 F 79 151 34.6 1.88 75 1.71 79 91 
4 SUBRAMANIAN 72 M 60 166 21.8 3.33 124 2.61 124 78.4 
5 RAGUNATHAN 59 M 70 172 23.7 3.48 99 2.64 95 75.9 
6 ABDUL RAHIM 73 M 82 174 27.1 2.98 92 2.38 94 79.9 
7 DEEPAK 23 M 72 169 25.2 4.59 111 3.56 101 77.6 
8 KUMAR 55 M 60 154 25.3 2.81 104 2.37 107 84.3 
9 MUNUSAMY 60 M 71 164 26.4 2.41 78 1.94 79 80.5 
10 AMUDHA 38 F 48 145 22.8 2.02 91 1.71 90 84.7 
11 VALRMATHI 40 F 38 143 18.6 2.04 97 1.86 104 91.2 
12 RAJA 38 M 60 163 22.6 3.28 93 2.9 97 88.4 
13 SARAVANAN 30 M 65 160 25.4 3.37 94 2.57 84 76.3 
14 RAKESH 24 M 104 176 33.6 5.01 112 4.22 112 84.2 
15 MARIMUTHU 36 M 85 162 32.4 3.34 95 2.6 87 77.8 
16 PRABHU 33 M 82 173 27.4 3.92 94 3.1 89 79.1 
17 THENNARASU 33 M 58 162 22.1 3.35 93 2.48 81 74 
18 SUDHA 32 F 73 165 26.8 2.6 83 2.25 83 86.5 
19 SRINIVASAN 28 M 70 174 23.1 4.56 106 3.22 88 70.6 
20 MANOJ KUMAR 28 M 77 160 30 2.87 80 2.59 83 90.2 
21 ERSHAD AHAMED 30 M 60 167 21.5 4.03 103 3.13 94 77.7 
22 VASUDEVAN 42 M 100 157 40.6 3.39 108 2.76 105 81.4 
 S. 
NO NAME AGE SEX 
WEIGHT 
(Kg) 
HEIGH
T (Cm) BMI 
FVC 
(Lit) FVC % 
FEV1 
(Lit) 
FEV1 
% 
FEV1/ 
FVC (%) 
23 RAJAKUMARI 39 F 70 152 30.3 1.9 77 1.67 79 87.9 
24 MURUGANANTAM 40 M 91 176 29.4 3.28 79 2.95 87 89.9 
25 LINGESHWARAN 40 M 82 175 26.8 3.87 95 3.26 96 84.2 
26 SARAVANAN 44 M 85 168 30.1 2.52 69 2.03 67 80.6 
27 BALARAMAN 42 M 92 173 30.7 3.66 93 2.92 90 79.8 
28 BALAMUGUNTHAN 40 M 85 173 28.4 3.31 83 2.78 84 84 
29 ELUMALAI 52 M 90 168 31.9 2.81 81 2.32 83 82.6 
30 GOVINDARAJAN 37 M 70 168 24.8 3.3 87 2.73 86 82.7 
31 DHANRAJ 35 M 75 170 26 4.49 114 3.73 113 83.1 
32 JAYAGOPAL 43 M 85 172 28.7 3.69 95 2.92 92 79.1 
33 MARIYAPPAN 45 M 70 172 23.7 4.15 108 3.59 115 86.5 
34 RAVIVARMAN 48 M 80 168 28.3 2.81 79 2.32 80 82.6 
35 JAYAKUMAR 36 M 93 168 33 3.14 82 2.81 88 89.5 
36 VELAVAN 35 M 78 178 24.6 3.93 90 3.44 95 87.5 
37 JAYANTHI 32 F 71 158 28.4 2.22 78 1.95 79 87.8 
38 NARAYANAN 41 M 62 170 21.5 3.45 90 2.85 90 82.6 
39 SATHISH 19 M 95 174 31.4 3.47 79 2.96 80 85.3 
40 THIYAGARAJAN 57 M 81 159 32 2.3 79 1.95 83 84.8 
41 PONRAM 20 M 56 175 18.9 4.07 92 3.18 85 78.1 
42 PUNITHA 60 F 78 148 35.6 1.19 65 1.05 69 88.2 
43 RAJAPPAN 57 M 82 164 30.5 2.4 76 2.09 83 87.1 
44 AKILA 36 F 58 155 24.1 2.51 95 2.18 96 86.9 
45 MANIKANDAN 28 M 82 183 24.5 4.33 91 3.38 85 78.1 
46 VIJAYA 26 F 62 164 23.1 3.08 96 2.78 99 90.3 
 S. 
NO NAME AGE SEX 
WEIGHT 
(Kg) 
HEIGH
T (Cm) BMI 
FVC 
(Lit) FVC % 
FEV1 
(Lit) 
FEV1 
% 
FEV1/ 
FVC (%) 
47 VINODHINI 20 F 40 150 17.8 2.74 101 2.31 98 84.3 
48 GANESH 29 M 104 178 32.8 4.21 94 3.63 97 86.2 
49 RAJARAMAN 45 M 90 165 33.1 2.55 73 2.24 78 87.8 
50 LOKESH 23 M 65 162 24.8 3.63 96 2.87 88 79.1 
51 SARITHA 37 F 59 168 20.9 2.87 92 2.28 84 79.4 
52 RAMAJAYAM 40 M 62 160 24.2 4.12 123 3.08 110 74.8 
53 HARIKRISHNAN 35 M 60 160 23.4 3.82 111 2.99 102 78.3 
54 DHANDAPANI 32 M 104 168 36.8 2.62 67 2.32 70 88.5 
55 RAJENDRAN 59 M 66 160 25.8 2.16 74 1.88 81 87 
56 PUNITHA 38 F 60 152 26 2.3 92 1.94 91 84.3 
57 KIRUBAKARAN 44 M 73 173 24.4 3.28 84 3.13 98 95.4 
58 SATHISHKUMAR 44 M 66 166 24 3.71 105 3.35 114 90.3 
59 DURAI RAJ 43 M 65 162 24.8 3.38 100 2.85 101 84.3 
60 KISHOREKUMAR 20 M 47 161 18.1 3.5 94 3.15 98 90 
61 VEERACHOLAN 40 M 83 165 30.5 4.17 116 3.33 111 79.9 
62 SASIKALA DEVI 52 F 70 152 30.3 1.76 81 1.52 83 86.4 
63 THANUPILLAI 63 M 50 155 20.8 2.22 86 1.96 96 88.3 
64 SIVAKUMAR 17 M 45 161 17.4 3.3 98 3.03 105 91.8 
65 KAVITHA JAYARAMAN 34 F 80 154 33.7 2.03 77 1.61 70 80.1 
66 SARALA 43 F 58 145 27.6 1.97 93 1.71 96 86.8 
67 VADIVEL 48 M 65 169 22.8 3.7 102 2.91 99 78.6 
68 SRILAKSHMI GAYATHIRI 14 F 63 163 23.7 2.74 95 2.52 99 92 
69 ARUL 42 M 60 173 20 3.7 94 3.02 93 81.6 
70 VELU 63 M 73 160 28.5 2.24 79 1.84 83 82.1 
 S. 
NO NAME AGE SEX 
WEIGHT 
(Kg) 
HEIGH
T (Cm) BMI 
FVC 
(Lit) FVC % 
FEV1 
(Lit) 
FEV1 
% 
FEV1/ 
FVC (%) 
71 VISHNUVARDHAN 30 M 74 170 25.6 3.41 84 2.93 85 85.9 
72 VIJAYA 57 F 61 155 25.4 1.93 89 1.67 91 86.5 
73 JAYANTHI 50 F 51 145 24.3 1.66 86 1.51 92 91 
74 SIVAPUSHPAM 51 F 43 140 21.9 1.89 109 1.64 114 86.8 
75 AKASH 20 M 49 167 17.6 4.01 100 3.48 101 86.8 
76 ISMOIL 21 M 87 167 31 3.01 75 2.83 82 94 
77 KAREEM 42 M 82 167 29.4 3.47 95 2.97 98 85.6 
78 MURUGAN 54 M 67 170 23.2 3.36 95 2.61 92 77.7 
79 VASUDEVAN 41 M 51 165 18.7 3.07 86 2.41 81 78.5 
80 VIJAY 17 M 65 148 29.7 2.13 79 1.7 74 79.8 
81 SOLOMON 10 M 31 139 16 1.94 97 1.57 89 80.9 
82 ELANGO 47 M 97 165 37 2.49 73 2.1 74 84.3 
83 ARUNKUMAR SARAVANAN 27 M 95 187 27.2 3.87 78 3.65 88 94.3 
84 SEKAR RAVICHANDRAN 53 M 73 167 26.2 3.17 94 2.71 99 85.5 
85 KAVITHA 34 F 52 147 24.1 2.08 87 1.75 85 84.1 
86 SHOBA 57 F 79 160 31 1.85 78 1.51 76 81.6 
87 VENKATACHALAM 46 M 64 161 24.7 3.06 94 2.29 85 74.8 
88 YUVARAJ 24 M 53 162 20.2 3.6 95 3.45 106 95.8 
89 LAKSHMANAN 38 M 80 160 31.2 2.49 74 2.2 77 88.4 
90 NARAYANAN 53 M 81 156 33.3 1.94 68 1.57 67 80.9 
91 MUTHU.S 44 M 69 179 21.5 3.37 80 3.08 90 91.4 
92 ANOOP 48 M 62 165 22.8 3.39 99 2.9 104 85.5 
93 DINESH BHAGAI 47 M 57 161 22 3.38 105 2.71 101 80.2 
94 MUTHUKRISHNAN 57 M 65 153 27.8 2.45 94 2.11 100 86.1 
 S. 
NO NAME AGE SEX 
WEIGHT 
(Kg) 
HEIGH
T (Cm) BMI 
FVC 
(Lit) FVC % 
FEV1 
(Lit) 
FEV1 
% 
FEV1/ 
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95 PREMKAMAL 45 M 91 175 29.7 3.66 92 3.33 102 91 
96 SHAJAHAN 35 M 60 173 20 3.7 90 3.18 93 85.9 
97 SUGAVANESHWARAN 31 M 88 177 28.1 3.91 89 3.09 84 79 
98 RAJASEELAN 31 M 89 178 28.1 3.57 80 3.21 87 89.9 
99 GANAPATHI 70 M 72 165 26.4 2.18 112 1.65 102 98 
100 DEERAN 23 M 90 170 31.1 1.81 74 1.46 70 98 
101 VENKATESAN 56 M 72 165 26.4 2.85 88 2.37 92 108 
102 SAKTHIVEL 42 M 105 182 31.7 3.93 90 3.51 98 112 
103 ANANDANE 42 M 87 175 28.4 3.95 98 3.54 107 112 
104 ANANDNAN 44 M 97 170 33.6 2.8 75 2.55 83 115 
105 RAMANAJAM 56 M 67 166 24.3 3.74 114 3.36 128 116 
106 VENGADASALABABY 38 M 68 168 24.1 3.73 99 3.39 107 113 
107 PAJANY 45 M 75 168 26.6 3.37 93 2.56 86 96 
108 TAMILARASAM 40 M 72 165 26.4 3.06 85 2.82 94 115 
109 AYOTTIRAMANE 44 M 68 167 24.4 3.27 91 2.57 86 99 
110 ULLAGANATHAN 54 M 76 172 25.7 3.33 92 2.8 96 109 
111 KARTHIKEYAN 47 M 78 170 27 3.2 87 2.76 92 110 
112 BABU 41 M 67 165 24.6 3.91 110 3 101 96 
113 DEVARASSU 58 M 81 165 29.8 2.42 76 2.17 85 117 
114 THANAGARASU 44 M 77 171 26.3 3.26 86 2.75 88 106 
115 CHELLAPERUMAL 29 M 74 175 24.2 4.64 107 3.69 101 97 
116 GANESAN 46 M 75 165 27.5 3.04 88 2.43 86 101 
117 SUBBU 34 M 85 173 28.4 4.62 112 4.14 120 110 
118 SASI KUMAR 37 M 74 167 26.5 3.12 83 2.78 88 111 
 S. 
NO NAME AGE SEX 
WEIGHT 
(Kg) 
HEIGH
T (Cm) BMI 
FVC 
(Lit) FVC % 
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(Lit) 
FEV1 
% 
FEV1/ 
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119 CHANDRASEKRAN 39 M 81 167 23.2 3.2 86 2.47 80 96 
120 VARADARASU 57 M 64 166 23.2 2.74 84 2.36 90 112 
121 VELU RAJ 34 M 71 169 24.9 3.56 91 3.23 98 112 
122 RAMAMOORTHY 44 M 66 165 24.2 3.05 87 2.55 88 105 
123 ASHARAF ALI 21 M 60 174 19.8 4.47 102 3.18 86 86 
124 PANNEER 54 M 65 172 22 3.44 95 2.72 93 102 
125 JOTHI 47 F 66 145 31.4 1.88 94 1.58 93 105 
126 AMEENUDEEN 59 M 78 170 27 3.66 107 3.01 111 107 
127 GUEDJENDIRAN 44 M 88 170 30.4 3.26 87 2.61 85 101 
128 ASHOKAN 43 M 74 182 22.3 4.1 94 3.14 88 96 
129 KUMAR 43 M 82 172 27.7 3.26 84 2.85 90 110 
130 ANBUAZHALAN 43 M 90 175 29.4 3.49 87 3.01 91 108 
131 LAKSHMAN 38 M 75 168 26.6 3.85 102 3.44 109 111 
132 RITHOSH CHANDRA 38 M 94 172 31.8 5.13 129 4.03 122 98 
133 MAHADEVAN 53 M 73 173 24.4 3.36 91 2.75 93 105 
134 GANDHI 35 M 94 179 29.3 4.04 92 3.57 98 109 
135 GOTHANDAPANI 47 M 86 172 29.1 3.03 80 2.65 86 111 
136 SRINI VASAN 36 M 86 172 29.1 4.09 101 3.43 102 104 
137 MAGESHWARAN 46 M 86 173 28.7 3.59 93 3.24 103 114 
138 PALANISAMY 46 M 98 170 33.9 3.19 86 2.67 88 106 
139 SHAZANA 45 M 80 173 26.7 3.54 91 3.01 95 107 
140 VELMURUGAN 30 M 65 173 21.7 3.53 83 3.2 90 111 
141 BALASUBRAMANI 28 M 61 175 19.9 3.8 87 3.03 83 97 
142 BOOSHAAM 53 F 70 160 27.3 2 82 1.67 80 106 
 S. 
NO NAME AGE SEX 
WEIGHT 
(Kg) 
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(Lit) 
FEV1 
% 
FEV1/ 
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143 KUMAR 55 M 60 154 25.3 2.83 105 2.38 108 109 
144 MURUGAN 35 M 70 163 26.3 3.39 94 3.05 100 111 
145 DEEP AKASH 21 M 71 174 23.5 4.57 115 3.95 115 100 
146 SUGAVANESHWARAN 31 M 88 177 28.1 3.91 89 3.09 84 97 
147 VEL MUTHU 20 M 60 166 21.8 3.72 93 3.29 96 107 
148 JAYAKUMAR 62 M 78 173 26.1 2.78 80 2.49 91 118 
149 SOORI 45 M 83 162 31.6 2.57 77 2.13 77 105 
150 MANI M ALA 48 F 60 156 24.7 2.3 95 1.83 89 100 
151 SARAVANA 30 M 65 160 25.4 3.37 94 2.57 84 93 
152 RASATHI 43 F 45 163 16.9 2.46 88 2.26 94 114 
153 KAPIL DEV 35 M 73 161 28.2 3.48 99 2.4 83 85 
154 GANESH 29 M 104 178 32.8 4.21 94 3.63 97 105 
155 SHANTHA 57 F 50 150 22.2 2.06 105 1.45 88 90 
156 SIDDHARATH 52 M 88 163 33.1 2.94 91 2.42 92 106 
157 YOVANGANDHI 47 M 72 169 25.2 4.03 111 3.44 116 108 
158 ANAND RAJ 55 M 70 158 28 2.19 76 1.81 77 107 
159 VELMURUGAN 34 M 83 164 30.9 2.9 78 2.43 77 103 
160 LAKSHMAN 38 M 80 160 31.2 2.64 78 2.31 81 109 
161 LAKSHMI 39 F 61 150 27.1 2.11 89 1.62 79 94 
162 JAME SUBBRAMANIYAN 41 M 83 164 30.9 2.79 79 2.36 81 106 
163 BRINDHA 18 F 38 158 15.2 2.7 90 2.25 86 99 
164 MAGESHWARI 26 F 63 155 26.2 2.53 88 2.26 90 106 
165 VALARMATHY 42 F 83 156 34.1 1.76 69 1.57 72 110 
166 SELVAM 46 M 83 168 29.4 3.23 90 2.6 88 102 
 S. 
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WEIGHT 
(Kg) 
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FEV1 
% 
FEV1/ 
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167 SUBARAMANIYAN 42 M 65 165 23.9 3 .00 85 2.49 84 104 
168 MARI MUTHU 49 M 63 172 21.3 3.31 89 2.95 97 114 
169 ETHAYATULLA 31 M 80 170 27.7 3.46 85 2.87 84 102 
170 VIJAYALAKSHMI 28 F 75 150 33.3 2.02 77 1.81 79 107 
171 MOHAN 45 M 65 165 23.9 3.38 97 2.77 97 104 
172 IYANARAPPAN 51 M 68 165 25 2.77 83 2.38 88 110 
173 THARAMAI SELVI 48 F 85 155 35.4 2.49 105 2.1 104 105 
174 MAGESHKUMAR 38 M 82 164 30.5 3.57 100 2.97 99 103 
175 VENGATESN 37 M 79 165 29 3.08 84 2.75 90 111 
176 THANADALVAN 53 M 91 176 29.4 3.24 84 2.76 90 110 
177 SARAVANAN 43 M 95 176 30.7 3.96 97 3.27 98 104 
178 SHAK 27 M 72 165 26.4 3.34 86 2.74 83 100 
179 ANANDHAKUMAR  35 M 65 162 24.8 3.08 87 2.65 88 106 
180 ZAHURDEEN 50 M 88 167 31.6 3.27 95 2.76 98 108 
181 GUGAN 25 M 83 162 31.6 3.43 91 2.88 88 102 
182 MUTHU 44 M 68 160 26.6 2.64 81 2.34 86 112 
183 REVATHY 53 F 70 153 29.9 1.76 81 1.53 83 110 
184 MOHAN 53 M 70 165 25.7 3.31 100 2.38 89 93 
185 RAMANATHAN 43 M 77 177 24.6 3.81 92 2.88 85 95 
186 SATHISH KUMAR 30 M 63 167 22 4.06 104 3.66 110 110 
187 KANNAN 40 M 80 163 30.1 2.64 76 2.38 82 113 
188 PRAKASH 27 M 100 175 32.7 4.04 92 3.47 94 104 
189 GNANARAJ 18 M 78 172 26.4 4.28 114 3.99 110 99 
190 MANIKANADAN 22 M 78 175 25.5 4.43 106 3.85 103 100 
 S. 
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(Kg) 
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T (Cm) BMI 
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191 RATHIKA 27 F 65 164 24.2 2.91 91 2.41 87 99 
192 RAHAMANAN 37 M 68 159 26.9 3.51 104 2.54 100 100 
193 SHANKAR 45 M 82 179 25.6 3.43 82 2.89 85 107 
194 KARTHICKEYAN 51 M 74 163 27.9 2.74 85 2.16 82 101 
195 PALANIAPPAN 48 M 68 165 25 3.29 96 2.9 104 112 
196 MAHENDRAKUMAR 45 M 73 174 24.1 3.4 87 2.95 92 110 
197 RAMALINGAM 44 M 79 168 28 2.91 80 2.59 86 112 
198 MUNIRA 38 F 63 156 25.9 2.45 93 2.08 92 104 
199 ELANGOVAN 48 M 74 168 26.2 3.75 105 2.9 100 98 
200 PURUSOTHAMMAN 49 M 61 160 23.8 2.97 95 2.42 94 104 
201 MANIKANDAN 25 M 82 165 30.1 3.05 78 2.55 75 101 
202 ANADVAN 41 M 63 164 23.4 3.13 88 2.85 96 114 
203 SENHIL 26 M 75 168 26.6 3.84 95 3.09 89 97 
204 HARI 25 M 70 168 24.8 3.65 89 3.16 91 105 
205 EGAMBARAM 53 M 78 172 26.4 3.08 84 2.33 80 97 
206 PERIYAMMAL 35 F 52 145 24.7 2.5 110 2.13 109 103 
207 RAJA 45 M 90 167 32.3 2.79 78 2.58 87 117 
208 RAJA RATAHINAM 36 M 90 167 32.3 4.04 96 3.53 101 108 
209 RAJENDRAN 51 M 70 175 22.9 3.68 96 2.64 85 92 
210 VIJAYAKUMARI 51 F 65 145 30.9 1.64 85 1.5 93 115 
211 ANBUSELVI 45 F 84 151 36.8 1.96 86 1.64 84 104 
212 XAVIER HONESTRAJ 26 M 73 170 25.3 4.27 103 3.28 93 93 
213 MURUGAIAN 47 M 78 173 26.1 3.28 86 2.76 88 107 
214 THANGARASU 54 M 80 170 27.7 3.11 88 2.68 95 111 
 S. 
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215 BAIAMURAGAN 45 M 76 176 24.5 3.23 80 2.95 90 115 
216 POVIARASAN 24 M 70 183 20.9 5.14 106 4.44 110 104 
217 RAMALINGAM 44 M 95 169 33.3 3.55 96 3.03 99 108 
218 RAMESH 45 M 70 172 23.7 3.96 103 3.43 110 109 
219 KIRSHNAMURTHY 44 M 60 170 20.8 3.53 94 2.73 89 97 
220 THIRUNAVUKARASU 42 M 67 166 24.3 3.2 89 2.65 89 104 
221 DEVANATHAN 43 M 93 172 31.4 3.77 97 3.4 107 113 
222 VEERAPPAN 57 M 63 157 25.6 2.58 92 2.28 100 115 
223 MURALI 30 M 84 178 26.5 3.86 87 3.11 83 99 
224 KANNAN 66 M 56 170 19.4 2.98 92 2.3 91 103 
225 BAVITHRA 34 F 68 182 25.5 2.7 91 2.17 84 97 
226 SENTHIL 32 M 76 163 28.6 3.09 84 2.54 81 101 
227 RAVIKUMAR 43 M 77 166 27.9 3.04 85 2.45 83 101 
228 THAIYAGU 31 M 74 177 23.6 3.64 83 2.6 71 88 
229 SUKUMAR 59 M 73 177 23.3 3.66 97 2.78 94 99 
230 ANANDARAJ 22 M 40 162 15.2 2.76 73 2.52 77 110 
231 RAJALAKSHMI 68 F 55 151 24.1 1.65 93 1.37 94 109 
232 JAYAKUMAR 62 M 78 173 26.1 3.21 92 2.52 92 103 
233 SARASHWATHI 47 F 71 155 29.6 2.03 85 1.72 84 106 
234 POONGKODI 31 F 57 156 23.4 2.58 92 1.99 82 93 
235 DINESH 30 M 87 176 28.1 4.64 106 3.69 101 97 
236 SUDHAKAR 33 M 70 166 25.4 3.27 86 3.05 95 115 
237 RAMACHANDRAN 46 M 80 161 30.9 2.84 87 2.28 84 102 
238 SHABANA 22 F 72 152 31,2 2.28 82 2.04 84 106 
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239 BHUVANESHWARI 61 F 64 147 29.6 1.93 109 1.73 118 116 
240 SUNDAR 55 M 83 169 29.1 3.15 91 2.41 87 99 
241 RAJENDRAN 51 M 90 162 34.3 2.31 72 2.08 80 115 
242 PRAVEENKUMAR 29 M 91 180 28.1 4.42 97 3.63 95 100 
243 SENTHIL 38 M 99 171 33.9 3.46 88 3.03 93 109 
244 MANIKKAVELU 45 M 72 165 26.4 3.07 88 2.54 89 105 
245 DHAKSHAYINI 30 F 57 154 24 2.34 85 1.98 83 101 
246 ROBERT 29 M 64 169 22.4 3.38 84 2.91 85 105 
247 DASS 42 M 57 157 23.1 2.68 85 2.13 81 100 
248 RAJESH 60 M 63 166 22.9 4.04 127 3.1 123 100 
249 KAVITHA 36 F 65 177 20.7 3.47 99 2.65 87 93 
250 GANAPATHY 19 M 45 162 17.1 3.26 103 2.87 104 104 
251 KANNIYAMMAL 45 F 41 143 20 2.2 111 2 120 113 
252 POONGODI 41 F 63 164 23.4 2.54 88 2.09 84 101 
253 SARAVANAN 35 M 65 178 20.5 3.89 89 2.87 80 91 
254 GAYATHRI 17 F 50 150 22.2 2.76 107 2.43 104 93 
255 MAHABBAT 21 M 51 157 20.7 4.06 115 3.04 99 91 
256 PRIYA 19 M 64 165 23.5 3.61 92 3.23 96 108 
257 PENCHELLAIACH 50 M 97 161 37.4 2.25 71 1.83 71 104 
258 AMLOPAVA MARY 52 F 65 158 26 2.19 94 1.91 97 110 
259 TALEEM ALILAS 26 M 53 155 22.1 3.01 89 2.4 81 97 
260 UJAL 23 M 64 172 21.6 3.9 91 3.54 97 110 
261 BHARATH 21 M 62 170 21.5 4.53 108 3.57 100 95 
262 SHANTU 24 M 80 174 26.4 4.02 92 3.19 86 96 
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263 MUKESH 22 M 86 178 27.1 4.59 100 3.86 100 102 
264 SUBHURADHA 29 M 50 164 18.6 3.8 101 2.65 82 85 
265 MANI 28 M 59 152 25.5 2.88 106 2.32 99 96 
266 CHAKRAGEUTAM 25 M 75 178 23.7 5.03 110 4.14 107 100 
267 ARUN 29 M 80 179 25 4.63 102 3.96 104 104 
268 DEVI 54 F 70 148 32 2.11 107 1.94 118 117 
269 VANTHY 30 F 55 148 25.1 2.51 100 2.06 94 98 
270 SARAVANAN 59 M 74 159 29.3 2.43 85 2.21 96 119 
271 RADHIKA 32 F 71 156 29.2 2.66 96 2.16 90 98 
272 MURALI 38 M 95 175 31 3.2 77 2.74 80 106 
273 RAJARAJAN 32 M 95 174 31.4 3.38 80 3.04 86 89.9 
274 VELMURUGN 20 M 60 166 21.8 3.72 93 3.29 96 88.4 
275 MURUGAN 35 M 70 163 26.3 3.39 94 3.05 100 90 
276 SHANMUGAM 44 M 80 172 27 3.3 86 2.83 90 85.8 
277 MURUGAN 29 M 76 172 25.7 3.4 81 2.9 82 85.3 
278 MURUGANPANDI 19 M 62 165 22.8 .4.00 102 3.49 103 87.3 
279 SWAMINATHAN 57 M 72 173 24.1 3.39 94 2.98 104 87.9 
280 GOPILAL 60 M 68 153 29 2.08 82 1.81 89 87 
281 ANSARI 20 M 54 164 20.1 3.67 95 3.04 91 82.8 
282 RANJIT 19 M 53 176 17.1 4.04 90 3.13 83 77.5 
283 SHAKUL 18 M 60 168 21.3 4.19 103 3.37 97 80.4 
284 MILANMALLIK 29 M 68 167 24.4 3.4 86 3.04 91 89.4 
285 LAKSHMI 50 F 45 150 20 2.14 122 1.74 119 81.3 
286 MAHIBULLA KHAN 22 M 55 `169 19.3 3.75 91 3.2 91 85.3 
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287 ADIKESAVAN 23 M 58 156 23.8 2.89 83 2.62 86 90.7 
288 MAGESHWARI 56 F 64 143 31.3 1.34 77 1.16 81 86.6 
289 BIMAN DASS 47 M 49 161 18.9 3.09 96 2.76 103 89.3 
290 IBRAHIM 19 M 54 153 23.1 2.94 89 2.48 85 84.4 
291 MUJUBUR 24 M 80 172 27 3.41 80 2.97 82 87.1 
292 KRISHNAN 42 M 86 178 26.2 3.35 80 2.73 79 81.5 
293 ARULKUMAR 27 M 67 167 24 3.23 81 2.77 81 85.8 
294 SANMATHI 21 F 50 155 20.8 3.07 106 2.59 103 84.4 
295 STALIN 30 M 56 163 21.1 3.07 83 2.56 81 83.4 
296 BASKAR 33 M 75 171 25.6 3.38 83 2.7 79 79.9 
297 MATHEW 40 M 78 165 28.7 3.34 93 2.94 98 88 
298 SAKTHI VIJAYAN 39 M 65 172 22 4.19 106 3.53 107 84.2 
299 KARTHIK 26 M 62 155 25.8 3.2 94 3.00 101 93.8 
300 MUTHURAMAN 37 M 79 161 30.5 2.82 82 2.46 84 87.2 
            
 
 
 
 
 
 
 
 
